- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 362473, 8 pages
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Therapy Promotes Functional Recovery of Contused Rat Spinal Cord through Enhancement of Endogenous Cell Proliferation and Oligogenesis
1Institute of Catholic Integrative Medicine (ICIM), Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea
2Department of Neurosurgery, The Catholic University of Korea, Seoul, Republic of Korea
3Medipost Biomedical Research Institute, Medipost Co., Ltd., Seoul, Republic of Korea
Received 23 June 2011; Accepted 29 September 2011
Academic Editor: Ken-ichi Isobe
Copyright © 2012 Sang In Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. P. Kurnellas, A. Nicot, G. E. Shull, and S. Elkabes, “Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury,” FASEB Journal, vol. 19, no. 2, pp. 298–300, 2005.
- J. W. McDonald and V. Belegu, “Demyelination and remyelination after spinal cord injury,” Journal of Neurotrauma, vol. 23, no. 3-4, pp. 345–359, 2006.
- L. J. Rosenberg and J. R. Wrathall, “Quantitative analysis of acute axonal pathology in experimental spinal cord contusion,” Journal of Neurotrauma, vol. 14, no. 11, pp. 823–838, 1997.
- L. Brundin, H. Brismar, A. I. Danilov, T. Olsson, and C. B. Johansson, “Neural stem cells: a potential source for remyelination in neuroinflammatory disease,” Brain Pathology, vol. 13, no. 3, pp. 322–328, 2003.
- G. Martino and S. Pluchino, “The therapeutic potential of neural stem cells,” Nature Reviews Neuroscience, vol. 7, no. 5, pp. 395–406, 2006.
- O. Lindvall and Z. Kokaia, “Stem cells for the treatment of neurological disorders,” Nature, vol. 441, no. 7097, pp. 1094–1096, 2006.
- S. Kabatas and Y. D. Teng, “Potential roles of the neural stem cell in the restoration of the injured spinal cord: review of the literature,” Turkish Neurosurgery, vol. 20, no. 2, pp. 103–110, 2010.
- T. L. Ben-Shaanan, T. Ben-Hur, and J. Yanai, “Transplantation of neural progenitors enhances production of endogenous cells in the impaired brain,” Molecular Psychiatry, vol. 13, no. 2, pp. 222–231, 2008.
- M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999.
- Y. Ogawa, K. Sawamoto, T. Miyata et al., “Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats,” Journal of Neuroscience Research, vol. 69, no. 6, pp. 925–933, 2002.
- Y. I. Tarasenko, J. Gao, L. Nie et al., “Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior,” Journal of Neuroscience Research, vol. 85, no. 1, pp. 47–57, 2007.
- S. E. Yang, C. W. Ha, M. H. Jung et al., “Mesenchymal stem/progenitor cells developed in cultures from UC blood,” Cytotherapy, vol. 6, no. 5, pp. 476–486, 2004.
- P. R. Sanberg, A. E. Willing, S. Garbuzova-Davis et al., “Umbilical cord blood-derived stem cells and brain repair,” Annals of the New York Academy of Sciences, vol. 1049, pp. 67–83, 2005.
- J. R. Pineda, N. Rubio, P. Akerud et al., “Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells,” Gene Therapy, vol. 14, no. 2, pp. 118–128, 2007.
- J. Chen, Y. Li, M. Katakowski et al., “Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat,” Journal of Neuroscience Research, vol. 73, no. 6, pp. 778–786, 2003.
- K. C. Wollert and H. Drexler, “Clinical applications of stem cells for the heart,” Circulation Research, vol. 96, no. 2, pp. 151–163, 2005.
- P. J. Horner and F. H. Gage, “Regenerating the damaged central nervous system,” Nature, vol. 407, no. 6807, pp. 963–970, 2000.
- B. H. Dobkin and L. A. Havton, “Basic advances and new avenues in therapy of spinal cord injury,” Annual Review of Medicine, vol. 55, pp. 255–282, 2004.
- D. M. Basso, M. S. Beattie, and J. C. Bresnahan, “Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection,” Experimental Neurology, vol. 139, no. 2, pp. 244–256, 1996.
- D. M. Basso, M. S. Beattie, and J. C. Bresnahan, “A sensitive and reliable locomotor rating scale for open field testing in rats,” Journal of Neurotrauma, vol. 12, no. 1, pp. 1–21, 1995.
- L. J. Zai and J. R. Wrathall, “Cell proliferation and replacement following contusive spinal cord injury,” Glia, vol. 50, no. 3, pp. 247–257, 2005.
- S. W. Yoo, S. S. Kim, S. Y. Lee et al., “Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model,” Experimental and Molecular Medicine, vol. 40, no. 4, pp. 387–397, 2008.
- L. J. Rosenberg, L. J. Zai, and J. R. Wrathall, “Chronic alterations in the cellular composition of spinal cord white matter following contusion injury,” Glia, vol. 49, no. 1, pp. 107–120, 2005.
- H. Yang, P. Lu, H. M. McKay et al., “Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury,” Journal of Neuroscience, vol. 26, no. 8, pp. 2157–2166, 2006.
- L. J. Zai, S. Yoo, and J. R. Wrathall, “Increased growth factor expression and cell proliferation after contusive spinal cord injury,” Brain Research, vol. 1052, no. 2, pp. 147–155, 2005.
- C. P. Hofstetter, E. J. Schwarz, D. Hess et al., “Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 2199–2204, 2002.
- Z. M. Zhao, H. J. Li, H. Y. Liu et al., “Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats,” Cell Transplantation, vol. 13, no. 2, pp. 113–122, 2004.
- J. R. Munoz, B. R. Stoutenger, A. P. Robinson, J. L. Spees, and D. J. Prockop, “Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 18171–18176, 2005.
- R. McKay, “Stem cells in the central nervous system,” Science, vol. 276, no. 5309, pp. 66–71, 1997.
- M. B. Newman, A. E. Willing, J. J. Manresa, C. D. Sanberg, and P. R. Sanberg, “Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair,” Experimental Neurology, vol. 199, no. 1, pp. 201–208, 2006.
- A. Erices, P. Conget, and J. J. Minguell, “Mesenchymal progenitor cells in human umbilical cord blood,” British Journal of Haematology, vol. 109, no. 1, pp. 235–242, 2000.
- Y. Li, J. Chen, X. G. Chen et al., “Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery,” Neurology, vol. 59, no. 4, pp. 514–523, 2002.
- Q. M. Li, Y. M. Fu, Z. Y. Shan et al., “MSCs guide neurite directional extension and promote oligodendrogenesis in NSCs,” Biochemical and Biophysical Research Communications, vol. 384, no. 3, pp. 372–377, 2009.